InsidersTradesSigma
Discover the full record of transactions filed by 横琴广金美好基金管理有限公司-广金美好费米十三号私募证券投资基金, Président. Director active across 1 companies, notably 博济医药. Aggregated, 5 reports have been published. Regulator: AMF. The full history is free.
5 of 5 declarations
Hengqin Guangjin Meihao Fund Management Co., Ltd. - Guangjin Meihao Fermi No. 13 Private Securities Investment Fund is chaired by an experienced leader in asset management. As chairman and CEO of Boji Pharmaceutical, he is responsible for investment strategy and overall company direction.